Supply Chain Security and Growth Act of 2025
Sponsor

Full profile: /officials/M000317
Source: Congress.gov · FEC
Cosponsors (12)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Jimmy Panetta (D-CA-19)Original· 2025-02-13
- Michael Lawler (R-NY-17)Original· 2025-02-13
- Mike Kelly (R-PA-16)Original· 2025-02-13
- Nydia M. Velázquez (D-NY-7)Original· 2025-02-13
- Pablo José Hernández (D-PR)Original· 2025-02-13
- Vern Buchanan (R-FL-16)Original· 2025-02-13
- Delia C. Ramirez (D-IL-3)· 2025-03-14
- Jim Costa (D-CA-21)· 2025-03-18
- Darren Soto (D-FL-9)· 2025-03-26
- Claudia Tenney (R-NY-24)· 2025-03-31
- Brian K. Fitzpatrick (R-PA-1)· 2025-06-04
- Eugene Simon Vindman (D-VA-7)· 2025-09-09
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2025-02-13
Previously
- Ways and Means CommitteeReferred To · 2025-02-13
Plain-English Summary
Supply Chain Security and Growth Act of 2025 This bill establishes a tax credit for qualified investments made in certain facilities that are located in a U.S. possession and manufacture drugs, pharmaceuticals, semiconductors, or certain other items, subject to limitations. The bill also increases the deemed-paid foreign tax credit for taxes paid to a U.S. possession. Specifically, under the bill, a taxpayer (other than a prohibited foreign entity) is allowed a tax credit for 40% of an investment in certain property that is placed into service during the tax year; integral to the operation of a critical supply chain facility; and constructed, reconstructed, or erected by the taxpayer, or property acquired for original used by the taxpayer. The bill defines critical supply chain facility as a facility that (1) manufactures active pharmaceutical ingredients, drugs, biologic products, medical countermeasures, medical diagnostic devices, semiconductors, semiconductor manufacturing equipment, aerospace equipment, or artificial nanomaterials; and (2) is located in Puerto Rico, Guam, American Samoa, the Northern Mariana Islands, or the Virgin Islands. Under the bill, the tax credit is transferable and may be claimed as a direct cash payment (i.e., elective payment). (Limitations apply.) Finally, the bill increases to 100% (from 80%) the deemed-paid foreign tax credit for income taxes paid or accrued by a controlled foreign corporation (CFC) to a U.S. possession. (Under current law, a U.S. shareholder of a CFC is allowed a tax credit for income taxes paid by a CFC on certain income attributable to the U.S. shareholder.)
Plain-English rewrite of the Congressional Research Service summary published on Congress.gov. Cached and reviewed.
Subjects
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR9064To amend the Internal Revenue Code of 1986 to temporarily increase the capital gains exclusion for any qualifying senior who sells a principal residence during a qualifying year, and for other purposes.Referred to Committee · 2026-05-29
- HR1329Smithsonian American Women’s History Museum ActPassed House · 2026-05-21
- HR8898End Government Pensions for Sexual Abusers Act of 2026Referred to Committee · 2026-05-19
- HR8796Federal Halo ActReferred to Committee · 2026-05-13